Loading...
Please wait, while we are loading the content...
Similar Documents
Testosterone and cardiovascular disease : controversy or wake-up call ?
| Content Provider | Semantic Scholar |
|---|---|
| Author | Yuen, Kevin C. J. |
| Copyright Year | 2014 |
| Abstract | In men with hypogonadism due to diseases of the hypothalamus, pituitary, or testis, testosterone therapy is generally safe and has been shown to induce beneficial effects. Conversely, in men with age-related low testosterone levels, the significance of this change and the effects of testosterone therapy are debatable. Studies have linked low testosterone levels with increased cardiovascular morbidity and mortality, with testosterone therapy being reported to improve cardiovascular risk profiles. However, two recent retrospective studies have fueled the controversy on testosterone therapy by reporting increased cardiovascular events. Because placebo-controlled, randomized clinical trials on testosterone therapy in older men with age-related decline in testosterone levels are lacking, long-term cardiovascular health following testosterone therapy in this patient population remains unclear. Therefore, a careful approach should be adopted when considering therapy of hypogonadism and coexisting cardiovascular disease in older men. Adequately powered, long-term prospective randomized trials on testosterone in older men are urgently needed. Cardiovasc Endocrinol 00:000–000 © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://universalmensclinic.com/wp-content/uploads/2014/10/TRT-CVD-review-paper-Sept-2014.pdf |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Cardiovascular Diseases Entity Name Part Qualifier - adopted Hypogonadism Hypothalamic structure Morbidity - disease rate Patients Power (Psychology) Prospective search Randomized algorithm Testosterone |
| Content Type | Text |
| Resource Type | Article |